▶ 調査レポート

世界の単一ドメイン抗体プラットフォーム市場

• 英文タイトル:Global Market Study on Single-Domain Antibody Platforms: Rising Adoption in Antiviral Drug Development Surging Market Growth

Global Market Study on Single-Domain Antibody Platforms: Rising Adoption in Antiviral Drug Development Surging Market Growth「世界の単一ドメイン抗体プラットフォーム市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR210107
• 出版社/出版日:Persistence Market Research / 2020年11月19日
• レポート形態:英文、PDF、233ページ
• 納品方法:Eメール
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User(1名用)¥661,500 (USD4,900)▷ お問い合わせ
  Site Licence(同一拠点内共有可)¥1,026,000 (USD7,600)▷ お問い合わせ
  Enterprise wide(複数拠点内共有可)¥1,431,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査資料では、世界の単一ドメイン抗体プラットフォーム市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、市場価格分析・予測、プラットフォーム種類別(マルチスペシフィック単一ドメイン抗体、二重特異性単一ドメイン抗体、多価単一ドメイン抗体、単一特異性単一ドメイン抗体)分析、動物由来別(ラクダ、サメ)分析、用途別(診断開発、治療法開発、研究・開発活動)分析、エンドユーザー別(診断研究所、臨床検査室、学術・研究機関、製薬・バイオテクノロジー企業)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。

・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・市場背景
・新型コロナウイルス感染症の危機分析
・市場価格分析・予測
・世界の単一ドメイン抗体プラットフォーム市場規模:プラットフォーム種類別(マルチスペシフィック単一ドメイン抗体、二重特異性単一ドメイン抗体、多価単一ドメイン抗体、単一特異性単一ドメイン抗体)
・世界の単一ドメイン抗体プラットフォーム市場規模:動物由来別(ラクダ、サメ)
・世界の単一ドメイン抗体プラットフォーム市場規模:用途別(診断開発、治療法開発、研究・開発活動)
・世界の単一ドメイン抗体プラットフォーム市場規模:エンドユーザー別(診断研究所、臨床検査室、学術・研究機関、製薬・バイオテクノロジー企業)
・世界の単一ドメイン抗体プラットフォーム市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法

Single-Domain Antibody Platforms Market – Scope of Report

A latest publication by Persistence Market Research (PMR) on the global single-domain antibody platforms market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global single-domain antibody platforms market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the single-domain antibody platforms market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for successful growth of the single-domain antibody platforms market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR). This research study can support readers to know the demand for single-domain antibody platforms and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the single-domain antibody platforms market space, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the single-domain antibody platforms market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the single-domain antibody platforms market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the single-domain antibody platforms market are also included in the current study. Depending on potential developments in the single-domain antibody platforms market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the single-domain antibody platforms industry can be aided in making suitable company choices to achieve traction in the market. Key Questions Answered in PMR’s Single-Domain Antibody Platforms Market Report

Which regions will continue to remain the most profitable regional markets for single-domain antibody platforms market players?
Which factors will induce a change in the demand for single-domain antibody platforms during the assessment period?
How will changing trends impact the single-domain antibody platforms market?
How can market players capture the low-hanging opportunities in the single-domain antibody platforms market in developed regions?
What are the winning strategies of stakeholders in the single-domain antibody platforms market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the single-domain antibody platforms market?
What are the developmental trends in single-domain antibody platform sectors that will impact the market?
How can businesses in the single-domain antibody platforms market avail growth the opportunities in developed and emerging sectors?
Single-Domain Antibody Platforms Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the single-domain antibody platforms market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the single-domain antibody platforms market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the single-domain antibody platforms market, and makes PMR’s projections on the growth prospects of the market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Rate/Usage Analysis- Key Statistics

4.2. Key Promotional Strategies, By Key Manufacturers

4.3. Key Regulations, By Region

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Industry Market Outlook

5.1.3. Global Life Science Market Outlook

5.2. Forecast Factors – Relevance & Impact

5.2.1. Research Activities

5.2.2. Key Players Historical Growth

5.2.3. Market Consolidation Activities

5.2.4. New Products Launches

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

6.1. Current COVID19 Statistics and Probable Future Impact

6.2. Current GDP Projection and Probable Impact

6.3. Current Economic Projection as compared to 2008 financial analysis

6.4. Quarter by Quarter Forecast

6.5. Projected recovery Quarter

6.6. COVID-19 Testing and Management

7. Global Single-Domain Antibody Platforms Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by Platform Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) By Platform Type, 2015-2019

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Platform Type, 2020-2030

8.3.1. Multi-specific Single-Domain Antibody

8.3.2. Bispecific Single-Domain Antibody

8.3.3. Multivalent Single-Domain Antibody

8.3.4. Mono-specific Single-Domain Antibody

8.4. Market Attractiveness Analysis by Platform Type

9. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by Animal Source

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) By Animal Source, 2015-2019

9.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Animal Source, 2020-2030

9.3.1. Camelids

9.3.1.1. Camels

9.3.1.2. Llama

9.3.1.3. Alpacas

9.3.2. Shark

9.4. Market Attractiveness Analysis By Platform Type

10. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by Application

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) and By Application, 2015-2019

10.3. Current and Future Market Size (US$ Mn) and Forecast By Application, 2020-2030

10.3.1.1. Diagnostic Development

10.3.1.2. Therapeutic Development

10.3.1.3. Research & Developmental Activities

10.4. Market Attractiveness Analysis by Application

11. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by End User

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030

11.3.1.1. Diagnostic Laboratories

11.3.1.2. Clinical Laboratories

11.3.1.3. Academic & Research Institutes

11.3.1.4. Pharmaceutical & Biotechnology Companies

11.4. Market Attractiveness Analysis By End User

12. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by Region

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018

12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. East Asia

12.3.5. South Asia

12.3.6. Oceania

12.3.7. Middle East and Africa (MEA)

12.4. Market Attractiveness Analysis By Region

13. North America Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

13.3.1. By Country

13.3.1.1. U.S.

13.3.1.2. Canada

13.3.2. By Platform Type

13.3.3. By Animal Source

13.3.4. By Application

13.3.5. By End User

13.4. Market Attractiveness Analysis

13.5. Drivers and Restraints – Impact Analysis

14. Latin America Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

14.3.1. By Country

14.3.1.1. Brazil

14.3.1.2. Mexico

14.3.1.3. Argentina

14.3.1.4. Rest of Latin America

14.3.2. By Platform Type

14.3.3. By Animal Source

14.3.4. By Application

14.3.5. By End User

14.4. Market Attractiveness Analysis

14.5. Drivers and Restraints – Impact Analysis

15. Europe Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030

15.3.1. By Country

15.3.1.1. Germany

15.3.1.2. Italy

15.3.1.3. France

15.3.1.4. U.K.

15.3.1.5. Spain

15.3.1.6. BENELUX

15.3.1.7. Russia

15.3.1.8. Rest of Europe

15.3.2. By Platform Type

15.3.3. By Animal Source

15.3.4. By Application

15.3.5. By End User

15.4. Market Attractiveness Analysis

15.5. Drivers and Restraints – Impact Analysis

16. South Asia Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

16.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030

16.3.1. By Country

16.3.1.1. India

16.3.1.2. Thailand

16.3.1.3. Indonesia

16.3.1.4. Malaysia

16.3.1.5. Rest of South Asia

16.3.2. By Platform Type

16.3.3. By Animal Source

16.3.4. By Application

16.3.5. By End User

16.4. Market Attractiveness Analysis

16.5. Drivers and Restraints – Impact Analysis

17. East Asia Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.2. By Platform Type

17.3.3. By Animal Source

17.3.4. By Application

17.3.5. By End User

17.4. Market Attractiveness Analysis

17.5. Drivers and Restraints – Impact Analysis

18. Oceania Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

18.3.1. By Country

18.3.1.1. Australia

18.3.1.2. New Zealand

18.3.2. By Platform Type

18.3.3. By Animal Source

18.3.4. By Application

18.3.5. By End User

18.4. Market Attractiveness Analysis

18.5. Drivers and Restraints – Impact Analysis

19. Middle East and Africa Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

19.3.1. By Country

19.3.1.1. GCC Countries

19.3.1.2. Turkey

19.3.1.3. South Africa

19.3.1.4. Rest of Middle East and Africa

19.3.2. By Platform Type

19.3.3. By Animal Source

19.3.4. By Application

19.3.5. By End User

19.4. Market Attractiveness Analysis

19.5. Drivers and Restraints – Impact Analysis

20. Key and Emerging Countries Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030

20.1. Introduction

20.1.1. Market Value Proportion Analysis, By Key Countries

20.1.2. Global Vs. Country Growth Comparison

20.2. U.S. Single-Domain Antibody Platforms Market Analysis

20.2.1. By Platform Type

20.2.2. By Animal Source

20.2.3. By Application

20.2.4. By End User

20.3. Canada Single-Domain Antibody Platforms Market Analysis

20.3.1. By Platform Type

20.3.2. By Animal Source

20.3.3. By Application

20.3.4. By End User

20.4. Mexico Single-Domain Antibody Platforms Market Analysis

20.4.1. By Platform Type

20.4.2. By Animal Source

20.4.3. By Application

20.4.4. By End User

20.5. Brazil Single-Domain Antibody Platforms Market Analysis

20.5.1. By Platform Type

20.5.2. By Animal Source

20.5.3. By Application

20.5.4. By End User

20.6. U.K. Single-Domain Antibody Platforms Market Analysis

20.6.1. By Platform Type

20.6.2. By Animal Source

20.6.3. By Application

20.6.4. By End User

20.7. Germany Single-Domain Antibody Platforms Market Analysis

20.7.1. By Platform Type

20.7.2. By Animal Source

20.7.3. By Application

20.7.4. By End User

20.8. France Single-Domain Antibody Platforms Market Analysis

20.8.1. By Platform Type

20.8.2. By Animal Source

20.8.3. By Application

20.8.4. By End User

20.9. Italy Single-Domain Antibody Platforms Market Analysis

20.9.1. By Platform Type

20.9.2. By Animal Source

20.9.3. By Application

20.9.4. By End User

20.10. Spain Single-Domain Antibody Platforms Market Analysis

20.10.1. By Platform Type

20.10.2. By Animal Source

20.10.3. By Application

20.10.4. By End User

20.11. Russia Single-Domain Antibody Platforms Market Analysis

20.11.1. By Platform Type

20.11.2. By Animal Source

20.11.3. By Age Group

20.11.4. By End User

20.12. China Single-Domain Antibody Platforms Market Analysis

20.12.1. By Platform Type

20.12.2. By Animal Source

20.12.3. By Application

20.12.4. By End User

20.13. Japan Single-Domain Antibody Platforms Market Analysis

20.13.1. By Platform Type

20.13.2. By Animal Source

20.13.3. By Application

20.13.4. By End User

20.14. South Korea Single-Domain Antibody Platforms Market Analysis

20.14.1. By Platform Type

20.14.2. By Animal Source

20.14.3. By Application

20.14.4. By End User

20.15. India Single-Domain Antibody Platforms Market Analysis

20.15.1. By Platform Type

20.15.2. By Animal Source

20.15.3. By Application

20.15.4. By End User

20.16. Indonesia Single-Domain Antibody Platforms Market Analysis

20.16.1. By Platform Type

20.16.2. By Animal Source

20.16.3. By Application

20.16.4. By End User

20.17. Australia Single-Domain Antibody Platforms Market Analysis

20.17.1. By Platform Type

20.17.2. By Animal Source

20.17.3. By Application

20.17.4. By End User

20.18. New Zealand Single-Domain Antibody Platforms Market Analysis

20.18.1. By Platform Type

20.18.2. By Animal Source

20.18.3. By Application

20.18.4. By End User

20.19. GCC Countries Single-Domain Antibody Platforms Market Analysis

20.19.1. By Platform Type

20.19.2. By Animal Source

20.19.3. By Application

20.19.4. By End User

20.20. South Africa Single-Domain Antibody Platforms Market Analysis

20.20.1. By Platform Type

20.20.2. By Animal Source

20.20.3. By Application

20.20.4. By End User

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies

21.2. Market Share Analysis of Top Players

21.3. Market Presence Analysis

21.3.1.1. Regional footprint of Players

21.3.1.2. Platform Type foot print by Players

21.3.1.3. Channel Foot Print by Players

22. Competition Analysis

22.1. Competition Dashboard

22.2. Competition Benchmarking

22.3. Competition Deep Dive

22.3.1. Creative BioLabs A

22.3.1.1. Overview

22.3.1.2. Platform Type Portfolio

22.3.1.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.1.4. Sales Footprint

22.3.1.5. Analyst Commentary

22.3.1.6. Strategy Overview

22.3.1.6.1. Marketing Strategy

22.3.1.6.2. Platform Type Strategy

22.3.1.6.3. Channel Strategy

22.3.2. Synbio Technologies

22.3.2.1. Overview

22.3.2.2. Platform Type Portfolio

22.3.2.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.2.4. Sales Footprint

22.3.2.5. Analyst Commentary

22.3.2.6. Strategy Overview

22.3.2.6.1. Marketing Strategy

22.3.2.6.2. Platform Type Strategy

22.3.2.6.3. Channel Strategy

22.3.3. ProSci Incorporated

22.3.3.1. Overview

22.3.3.2. Platform Type Portfolio

22.3.3.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.3.4. Sales Footprint

22.3.3.5. Analyst Commentary

22.3.3.6. Strategy Overview

22.3.3.6.1. Marketing Strategy

22.3.3.6.2. Platform Type Strategy

22.3.3.6.3. Channel Strategy

22.3.4. BioCat GmbH

22.3.4.1. Overview

22.3.4.2. Platform Type Portfolio

22.3.4.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.4.4. Sales Footprint

22.3.4.5. Analyst Commentary

22.3.4.6. Strategy Overview

22.3.4.6.1. Marketing Strategy

22.3.4.6.2. Platform Type Strategy

22.3.4.6.3. Channel Strategy

22.3.5. Antibody Design Labs

22.3.5.1. Overview

22.3.5.2. Platform Type Portfolio

22.3.5.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.5.4. Sales Footprint

22.3.5.5. Analyst Commentary

22.3.5.6. Strategy Overview

22.3.5.6.1. Marketing Strategy

22.3.5.6.2. Platform Type Strategy

22.3.5.6.3. Channel Strategy

22.3.6. GenScript

22.3.6.1. Overview

22.3.6.2. Platform Type Portfolio

22.3.6.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.6.4. Sales Footprint

22.3.6.5. Analyst Commentary

22.3.6.6. Strategy Overview

22.3.6.6.1. Marketing Strategy

22.3.6.6.2. Platform Type Strategy

22.3.6.6.3. Channel Strategy

22.3.7. Oak BioSciences, Inc.

22.3.7.1. Overview

22.3.7.2. Platform Type Portfolio

22.3.7.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.7.4. Sales Footprint

22.3.7.5. Analyst Commentary

22.3.7.6. Strategy Overview

22.3.7.6.1. Marketing Strategy

22.3.7.6.2. Platform Type Strategy

22.3.7.6.3. Channel Strategy

22.3.8. Rockland Immunochemicals, Inc

22.3.8.1. Overview

22.3.8.2. Platform Type Portfolio

22.3.8.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.8.4. Sales Footprint

22.3.8.5. Analyst Commentary

22.3.8.6. Strategy Overview

22.3.8.6.1. Marketing Strategy

22.3.8.6.2. Platform Type Strategy

22.3.8.6.3. Channel Strategy

22.3.9. Hybrigenics Services

22.3.9.1. Overview

22.3.9.2. Platform Type Portfolio

22.3.9.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.9.4. Sales Footprint

22.3.9.5. Analyst Commentary

22.3.9.6. Strategy Overview

22.3.9.6.1. Marketing Strategy

22.3.9.6.2. Platform Type Strategy

22.3.9.6.3. Channel Strategy

22.3.10. NeoClone Biotechnology International LLC

22.3.10.1. Overview

22.3.10.2. Platform Type Portfolio

22.3.10.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.10.4. Sales Footprint

22.3.10.5. Analyst Commentary

22.3.10.6. Strategy Overview

22.3.10.6.1. Marketing Strategy

22.3.10.6.2. Platform Type Strategy

22.3.10.6.3. Channel Strategy

22.3.11. Kaneka Eurogentec S.A

22.3.11.1. Overview

22.3.11.2. Platform Type Portfolio

22.3.11.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.11.4. Sales Footprint

22.3.11.5. Analyst Commentary

22.3.11.6. Strategy Overview

22.3.11.6.1. Marketing Strategy

22.3.11.6.2. Platform Type Strategy

22.3.11.6.3. Channel Strategy

22.3.12. ProteoGenix

22.3.12.1. Overview

22.3.12.2. Platform Type Portfolio

22.3.12.3. Profitability by Market Segments (Platform Type/Channel/Region)

22.3.12.4. Sales Footprint

22.3.12.5. Analyst Commentary

22.3.12.6. Strategy Overview

22.3.12.6.1. Marketing Strategy

22.3.12.6.2. Platform Type Strategy

22.3.12.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Table 1: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type

Table 2: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Source

Table 3: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application

Table 4: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 5: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 6: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type

Table 7: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources

Table 8: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application

Table 9: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 10: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 11: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type

Table 12: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources

Table 13: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application

Table 14: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 15: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 16: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type

Table 17: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources

Table 18: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application

Table 19: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 20: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 21: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type

Table 22: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources

Table 23: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application

Table 24: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 25: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 26: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type

Table 27: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources

Table 28: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application

Table 29: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 30: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 31: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type

Table 32: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources

Table 33: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application

Table 34: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 35: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 36: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type

Table 37: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources

Table 38: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application

Table 39: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 40: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country